The Certificate in Psychedelic-Assisted Therapies (CPAT) has been developed primarily to meet the anticipated demand for trained therapists to provide regulatory-approved and research-backed psychedelic-assisted therapies for the treatment of mental ill-health in Australia. It is also expected that trained clinicians will be needed to work in research trials as they expand in the Australia.
It follows the model of the world-leading course developed by the California Institute of Integral Studies (CIIS) (Phelps, 2017) in collaboration with the Multidisciplinary Association for Psychedelic Studies (MAPS), modified to suit the population and needs of an Australian and Asia-Pacific population.
The program broadly follows the main topic areas and format of these two programs, with a strong overlap in course materials, teachers/presenters and methods of teaching.
Mind Medicine Australia has devised a course based on the CIIS curriculum, as far as possible, within the Australian context (Phelps, 2017). This has incorporated teaching material that is
used in programs at the forefront of the psychedelic world – MAPS, USONA, and others.
Mind Medicine Australia appointed a Manager of Course Development, Renee Harvey, Clinical Psychologist, to work full time in devising this course, together with the support of a Steering Committee. Renee built her knowledge and skill in the field of psychedelic medicine and therapy through training and participating in the psychedelic research program at Imperial College, London.
The development of the MMA program has relied on significant collaboration with colleagues with considerable skill and knowledge. The teaching program incorporates live face-to-face lectures and webcasts, and direct teaching of skills and experiential workshops led by this team. For more details of members of the Steering Committee and teaching team please see below.
While incorporating the best of components from courses overseas, the Certificate in Psychedelic-Assisted Therapies is also offered in the spirit of respect and acknowledgement of the local context within Australia. The 2021 program is the very first course of its kind in the Southern Hemisphere.
Mind Medicine Australia has listened to feedback from people keen to participate and has developed the course length and requirements to be accessible to people who are travelling from all over Australia and beyond. We also understand the need to make the course as widely available as possible to working therapists, who have time and financial pressures shaping their capacity to meet the demands of the course.
The original courses require practical elements – participation in research programs, etc., which are not yet as widely available in Australia as overseas. Mind Medicine Australia has nonetheless been committed to maintaining the highest quality possible, and so the course presents academic, didactic and skills development components in a similar hybrid model of online, live and self-study components as the CIIS course. We expect that as the course grows and graduates establish themselves and more opportunities will arise, including the possibility of incorporating learning by placements, shadowing, etc.
We also offer a Psychological Support Service currently, part of which enables clinicians working in the field to access supervision and on-going professional development – more
We are also aware that there is a very long history of traditional use of these substances (as well as others not as well known) and practices for various healing and spiritual growth
purposes in every continent in the world. Teaching about this history is part of the course. Incorporating input from traditional practitioners from various sources is an ambition we hold
with high value for the future as reality permits.
For now, our focus is to start with training therapists primarily focussed on meeting the needs of the mental health crisis, working within research programs and a medically supported
environment, and providing integrative and other therapeutic work with the users of these substances.
The course will take place over a period of 4 months, with:
The Certificate in Psychedelic-Assisted Therapies course aims to build on skills already acquired and used by professionals working in various therapeutic contexts. Applicants must have as a minimum a Bachelor level degree in a field relevant to mental health, plus at least 3 years of documented supervised practice in a mental health field.
On this basis, people with the following qualifications may apply:
Acceptance onto the course will rest on three main factors:
The focus of Mind Medicine Australia is on the clinical application of medicinal psilocybin and medicinal MDMA for certain classes of mental illness in a regulatory approved manner. At the current time, these treatments are only legally available in Australia in particular circumstances (which can differ from State to State), and then only after specific regulatory approvals have first been obtained. Given this legal position we cannot accept any person into the course if we believe, on reasonable grounds, that that person is using or intends to use, these treatments in breach of the law. We also cannot condone in any way the illegal use of these substances.
Application fee: $150 (non-refundable)
Course fee: $7500 (or $7000 upfront payment in full)
Course 1: 23 January to 22 May 2021
Pre-reading: Will be emailed on 13 December 2020
|First meeting:||23 January 2021|
|Final meeting:||22 May 2021|
|Week-long Intensive:||25 to 30 April 2021|
|Final submission of coursework:||31 May 2021|
|Supervised practice:||To be arranged*|
Course 2: 26 June to 9 October 2021
Pre-reading: Will be emailed on 21 May 2021
|First meeting:||26 June 2021|
|Final meeting:||9 October 2021|
|Week-long Intensive:||12 to 17 September 2021|
|Final submission of coursework:||16 October|
|Supervised practice:||To be arranged*|
* Subject to regulatory requirements
1 June 2020 (Applicants will be considered in order of receipt. We expect the program to be over-subscribed so please register early to avoid disappointment.)
Screening and interview/finalise applicants:
Step 1: Complete the Application Form.
Step 2: Send your $150 application processing fee including your initial course fee ($7150 – discounted upfront full fee or $2650 part fee): Mind Medicine Australia via Paypal or Credit Card Payment (part of the application form).
Step 3: Applications will be screened, and if successful invited to an interview in July.
Step 4: Final decision, and invitation to join the course.
PH. D, FAPS, BA (HONS), BSC, MPSYCH
Professor Greg Murray, PhD is an Australian academic clinical psychologist. He is Director of Swinburne University’s Centre for Mental Health, a Fellow of the Australian Psychological Society, and patron of Bipolar Life. He has a national and international reputation for mental health research, being ranked in the top 1% of researchers worldwide in the fields of bipolar disorders, circadian rhythms, personality and affect.
Greg has won multiple individual awards for research and teaching, and delivered professional development workshops for hundreds of psychologists and psychiatrists across Australia and overseas.
BA (Hons), AdvDip GradCert AdvCert (Counselling), MA
Sean O’Carroll is a psychotherapist in private practice in Melbourne, Australia. He has a background in philosophy, transpersonal psychology, and a number of psychotherapeutic modalities including relational gestalt therapy and creative arts therapy. He has been teaching and training psychotherapists since 2011, and is the director of Wild Mind. His MA research thesis (2014 – 2017) involved a phenomenological exploration into the experience of being alone with nature, and in 2018 he developed and delivered Australia’s first tertiary level course in eco-psychotherapy to training therapists.
Sean’s work under the banner of Wild Mind employs non-ordinary states of consciousness to support health and wholeness. This work is grounded in various state-change technologies including dance/movement, nature-based practices and a variety of other psychotherapeutic processes. Sean does not facilitate psychedelic journeys for legal reasons, but works closely with members of the Melbourne medicine community in a psychotherapeutic capacity, supporting the exploration and integration of psychedelic experiences.
Ph. D Psychology, B. A Social Work (MHSW)
Dr Alana Roy is a psychologist, social worker and therapist and has spent the last 13 years working in mental health, suicide prevention, trauma, sexual abuse and family violence and the disability sector. She is dedicated to psychedelic assisted psychotherapy and plant medicines. She has engaged with, and provides integration therapeutic support services for communities across Australia. Alana works at several universities as a Research Fellow and supervisor of students on placement.
Alana passionately advocates for public policy, community education and legislative changes so that these treatments are regulated and supported by a strong, connected and skilled sector. Alana utilizes a range of therapies such as emotion-focused therapy, Eye Movement Desensitization and Reprocessing (EMDR), cognitive-behavioural therapy, neuro linguistic programming, acceptance and commitment therapy and mindfulness and meditation approaches. In Alana’s spare time she is kept busy by her young sons, her love of travelling the world, and connecting with the diverse and creative medicine community.
Manager of the Psychedelic Therapy Development Program
Renee has had a long career as a Consultant Clinical Psychologist in the NHS in the UK. More recently she was an Honorary Research Fellow at Imperial College London in the study of psilocybin for treatment resistant depression. She has been responsible for leading in service development for people with complex emotional needs across Sussex (UK), establishing three specialist services, including staff appointments, training and supervision, and in clinical delivery in these services.
She established various training courses and treatment programmes during this time, and regularly delivered lectures and courses at various levels. Renee specialised in training clinicians in skills for working with individuals with complex needs across the UK as well as internationally, including Europe, and Japan. Renee was also a key member of developing psychedelic interest groups in Brighton, and in establishing and running a psychedelic Integration Circle in Brighton UK.
Mind Medicine Australia has developed a safe and professional psychological service for those who want support regarding psychedelics, plant medicines, and their emotional health and wellbeing.
By submitting an enrolment application for the Certificate in Psychedelic-Assisted Therapies (CPAT), you acknowledge that you have read and accepted these Terms and Conditions.
*Subject to regulatory requirements
Mind Medicine Australia is seeking to establish safe and effective psychedelic-assisted therapies for the treatment of mental illness in Australia. MMA is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for the treatment of certain mental illnesses.
We do not advocate for recreational use of psychedelics, MDMA, or any other prohibited substances*, nor do we advocate for any changes to the law with respect to recreational use. Our focus is wholly clinical.
Mind Medicine Australia requires allied health professionals, psychotherapists and general participants wishing to participate in the Certificate in Psychedelic-Assisted Therapies to agree to the following Code of Conduct during the professional development program.
Participants will not:
Failure to follow these guidelines could result in losing a place in the CPAT program.
Thank you for working with us to ensure that we deliver a high quality, safe and reputable CPAT program.
* Psychedelics or psychedelic substances are described as ‘psychoactive substances’ by the Victoria State Government.